172 related articles for article (PubMed ID: 15039214)
1. IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS.
Heckmann A; Waltzinger C; Jolicoeur P; Dreano M; Kosco-Vilbois MH; Sagot Y
Am J Pathol; 2004 Apr; 164(4):1253-62. PubMed ID: 15039214
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-specific deletion of IKK2 or NEMO mediates an increase in intrarenal Th17 cells and accelerates renal damage in an ischemia-reperfusion injury mouse model.
Guo L; Lee HH; Noriega ML; Paust HJ; Zahner G; Thaiss F
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F1005-F1014. PubMed ID: 27582100
[TBL] [Abstract][Full Text] [Related]
3. Cellular immune reaction in the pancreas is induced by constitutively active IkappaB kinase-2.
Aleksic T; Baumann B; Wagner M; Adler G; Wirth T; Weber CK
Gut; 2007 Feb; 56(2):227-36. PubMed ID: 16870717
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease.
Hanna Z; Kay DG; Cool M; Jothy S; Rebai N; Jolicoeur P
J Virol; 1998 Jan; 72(1):121-32. PubMed ID: 9420207
[TBL] [Abstract][Full Text] [Related]
5. Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir.
Bisset LR; Rothen M; Joller-Jemelka HI; Dubs RW; Grob PJ; Opravil M
AIDS; 1997 Mar; 11(4):485-91. PubMed ID: 9084796
[TBL] [Abstract][Full Text] [Related]
6. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.
Cai D; Frantz JD; Tawa NE; Melendez PA; Oh BC; Lidov HG; Hasselgren PO; Frontera WR; Lee J; Glass DJ; Shoelson SE
Cell; 2004 Oct; 119(2):285-98. PubMed ID: 15479644
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling.
Giannopoulou M; Dai C; Tan X; Wen X; Michalopoulos GK; Liu Y
Am J Pathol; 2008 Jul; 173(1):30-41. PubMed ID: 18502824
[TBL] [Abstract][Full Text] [Related]
8. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
9. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
10. Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells.
Frelin C; Imbert V; Griessinger E; Peyron AC; Rochet N; Philip P; Dageville C; Sirvent A; Hummelsberger M; Bérard E; Dreano M; Sirvent N; Peyron JF
Blood; 2005 Jan; 105(2):804-11. PubMed ID: 15454494
[TBL] [Abstract][Full Text] [Related]
11. Skeletal and cardiac myopathy in HIV-1 transgenic rats.
Pruznak AM; Hong-Brown L; Lantry R; She P; Frost RA; Vary TC; Lang CH
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E964-73. PubMed ID: 18713959
[TBL] [Abstract][Full Text] [Related]
12. Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells.
Caposio P; Musso T; Luganini A; Inoue H; Gariglio M; Landolfo S; Gribaudo G
Antiviral Res; 2007 Mar; 73(3):175-84. PubMed ID: 17070604
[TBL] [Abstract][Full Text] [Related]
13. Activation of p21-activated kinase 2 and its association with Nef are conserved in murine cells but are not sufficient to induce an AIDS-like disease in CD4C/HIV transgenic mice.
Vincent P; Priceputu E; Kay D; Saksela K; Jolicoeur P; Hanna Z
J Biol Chem; 2006 Mar; 281(11):6940-54. PubMed ID: 16407193
[TBL] [Abstract][Full Text] [Related]
14. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.
Grinspoon S; Corcoran C; Miller K; Biller BM; Askari H; Wang E; Hubbard J; Anderson EJ; Basgoz N; Heller HM; Klibanski A
J Clin Endocrinol Metab; 1997 May; 82(5):1332-7. PubMed ID: 9141512
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic analysis of human herpes virus 8-encoded viral FLICE inhibitory protein-induced NF-kappaB activation.
Matta H; Sun Q; Moses G; Chaudhary PM
J Biol Chem; 2003 Dec; 278(52):52406-11. PubMed ID: 14561765
[TBL] [Abstract][Full Text] [Related]
16. Induction of RANTES/CCL5 by herpes simplex virus is regulated by nuclear factor kappa B and interferon regulatory factor 3.
Melchjorsen J; Paludan SR
J Gen Virol; 2003 Sep; 84(Pt 9):2491-2495. PubMed ID: 12917470
[TBL] [Abstract][Full Text] [Related]
17. NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes.
Aupperle K; Bennett B; Han Z; Boyle D; Manning A; Firestein G
J Immunol; 2001 Feb; 166(4):2705-11. PubMed ID: 11160335
[TBL] [Abstract][Full Text] [Related]
18. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel and selective IKK-beta serine-threonine protein kinase inhibitors. Part 1.
Murata T; Shimada M; Sakakibara S; Yoshino T; Kadono H; Masuda T; Shimazaki M; Shintani T; Fuchikami K; Sakai K; Inbe H; Takeshita K; Niki T; Umeda M; Bacon KB; Ziegelbauer KB; Lowinger TB
Bioorg Med Chem Lett; 2003 Mar; 13(5):913-8. PubMed ID: 12617920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
